Department of Pharmaceutics, Pharmaceutical Materials Science and Engineering Laboratory, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455.
Small Molecule Design and Development, Lilly Research Labs, Eli Lilly and Company, Indianapolis, Indiana 46285.
J Pharm Sci. 2019 Apr;108(4):1396-1400. doi: 10.1016/j.xphs.2018.11.015. Epub 2018 Nov 15.
Direct compression (DC) is the easiest and most cost-effective process for tablet manufacturing, because it only involves blending and compression. However, active pharmaceutical ingredients generally exhibit poor mechanical and micromeritic properties, which necessitate dilution and the use of high percentage of excipients to enable a robust DC manufacturing process. Consequently, drug loading in DC tablets is usually low (typically <30%, w/w). In this study, spherical crystallization by the quasi-emulsion solvent diffusion method was used to engineer a poorly flowing model compound, ferulic acid (FA), to attain superior mechanical properties, particle size distribution, and morphology. The engineered FA particles enabled the successful development of DC tablets containing 99% FA, which is in sharp contrast to the maximum 10% FA loading using as-received FA. The record high active pharmaceutical ingredient loading in this work illustrates the potential for spherical crystallization to enable high drug loading when developing a tablet product using the DC manufacturing process.
直接压缩(DC)是制造片剂最简便、最具成本效益的工艺,因为它仅涉及混合和压缩。然而,活性药物成分通常表现出较差的机械和微粉学性质,这需要稀释并使用高比例的赋形剂来实现稳健的 DC 制造工艺。因此,DC 片剂中的药物载量通常较低(通常 <30%,w/w)。在这项研究中,采用准乳液溶剂扩散法进行球形结晶,对流动性差的模型化合物阿魏酸(FA)进行了工程设计,以获得优异的机械性能、粒度分布和形态。工程化的 FA 颗粒使得能够成功开发出含有 99% FA 的 DC 片剂,与使用原始 FA 时最高 10% FA 载量形成鲜明对比。本工作中记录的高活性药物成分载量表明,球形结晶在使用 DC 制造工艺开发片剂产品时具有实现高药物载量的潜力。